Directorate Change

Finsbury Emerging Biotechnology Tst
27 March 2006

                                                                    News Release
                                                                   27 March 2006





                FINSBURY EMERGING BIOTECHNOLOGY TRUST PLC


                          APPOINTMENT OF NEW DIRECTOR



The Board of Finsbury Emerging Biotechnology Trust PLC is delighted to announce
the appointment of Mr Sven Borho, CFA, as a non-executive director to the
Company with immediate effect.



Mr Borho is a founding General Partner of OrbiMed Advisors LLC ("OrbiMed"), the
Company's Investment Adviser.  He is a portfolio manager for OrbiMed's public
equity funds and heads the firm's trading activities.  He started his career in
1991 when he joined Mehta and Isaly as a Senior Analyst covering European
pharmaceutical firms and biotechnology companies worldwide.



There are no matters to be disclosed under Listing Rule 9.6.13 (1) to (6)
inclusive in respect to the appointee.







For and on behalf of the Board


Close Finsbury Asset Management Limited
Company Secretary



For further information please contact:

Tracey Lago, Close Finsbury Asset Management Ltd                020 7426 6219
Alastair Smith, Close Finsbury Asset Management Ltd             020 7426 6240


                      This information is provided by RNS
            The company news service from the London Stock Exchange